ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies

Monday, November 19, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

BUDAPEST and GRAZ, Austria, November 19 ThalesNano Inc.and the Christian Doppler Laboratory for Microwave Chemistry (CDLMC) locatedat Karl-Franzens-University in Graz today announced a scientificcollaboration on flow/microwave chemistry research. The project will focus onthe application of flow reactors for organic synthesis and the development ofnovel technologies utilizing ThalesNano's background in continuousprocessing. ThalesNano and the Christian Doppler Research Association (CDG)will jointly provide financial support for the collaboration.

Dr. Laszlo Urge, CEO of ThalesNano Inc, said "We joined forces with oneof the leading research laboratories in Europe for the application of ourtechnologies. This will enable us to jointly develop novel methods andenvironmentally friendly solutions with our technology. The Christian DopplerResearch Association in Austria provides a great example on how toeffectively support basic and applied research and innovation. The ChristianDoppler Laboratory for Microwave Chemistry under the leadership of ProfessorC. Oliver Kappe has proven over the last several years how the adaptation ofnew technologies can impact the development of science and technology in thefield of chemistry. We expect that the collaboration results in furtherinnovations."

Professor Kappe, the Director of the CDLMC, commented "We believe thatthis collaboration with ThalesNano, one of the leading companies involved inflow chemistry instrument and application development will result in thecreation of further important technologies, from which the entire chemistrycommunity in both academia and industry could benefit from.

Professor Ferenc Darvas, president and chairman of ThalesNano Inc. said:"This agreement emphasizes that collaborations between academia and industryare essential and can create economically viable results. The ChristianDoppler Laboratory for Microwave Chemistry is leading scientific applicationdevelopment and contributed significantly to the general acceptance ofmicrowave technologies so far."

For more information please go to:

About ThalesNano Inc.

ThalesNano is a world-leading provider of flow chemistry instruments forlaboratories with well over 50% share on the explosively developing market oflaboratory flow reactors. Its H-CubeTM , continuous-flow hydrogenationreactors with no outside hydrogen gas source (also available for scale up),has been used in hundreds of labs in four continents. After being awarded asone of the 100 most technologically significant and innovative new productsof 2005 by the R&D Magazine, ThalesNano this year successfully generalizedthe concept of H-Cube by creating and bringing to the market the X-Cube, ahigh-pressure, high-temperature general purpose flow reactor for liquid orliquid/gas phase reactions. Apart from instrument development, ThalesNanoprovides synthetic and scale-up solutions to the industry, together withtraining and technical support.

Flow chemistry, an emerging technology allows the highly effective andrapid synthesis of organic compounds, in particular under hithertounrealizable hazardous reaction conditions. Additional benefits are seen inthe area of green chemistry and lab automation. This technology furthermorepromotes the rapid scale-up from mg to kg quantities with quick turnover,high quality stabilization, and reduced footprint leading to minimized CAPEXand OPEX

About Christian Doppler Research Association

The Austrian Christian Doppler Research Association (CDG) is a non-profitassociation that aims at promoting application oriented basic research in theareas of natural sciences, technology and economy. It enables talentedscientists in renowned research centers to achieve high-quality research andknowledge transfer in line with the demands and to the advantage of the CDGmember companies. The CD L

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store